Progress towards hepatitis C virus elimination in high‐income countries: An updated analysis
- 2 January 2021
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 41 (3) , 456-463
Abstract
BACKGROUND & AIMS: Elimination of HCV by 2030, as defined by the World Health Organization (WHO), is attainable with the availability of highly efficacious therapies. This study reports progress made in the timing of HCV elimination in 45 high‐income countries between 2017 and 2019.METHODS: Disease progression models of HCV infection for each country were updated with latest data on chronic HCV prevalence, and annual diagnosis and treatment levels, assumed to remain constant in the future. Modelled outcomes were analysed to determine the year in which each country would meet the WHO 2030 elimination targets.RESULTS: Of the 45 countries studied, 11 (Australia, Canada, France, Germany, Iceland, Italy, Japan, Spain, Sweden, Switzerland, and United Kingdom) are on track to meet WHO's elimination targets by 2030; five (Austria, Malta, Netherlands, New Zealand, and South Korea) by 2040; and two (Saudi Arabia and Taiwan) by 2050. The remaining 27 countries are not expected to achieve elimination before 2050. Compared to progress in 2017, South Korea is no longer on track to eliminate HCV by 2030, three (Canada, Germany, and Sweden) are now on track, and most countries (30) saw no change.CONCLUSIONS: Assuming high‐income countries will maintain current levels of diagnosis and treatment, only 24% are on track to eliminate HCV by 2030, and 60% are off track by at least 20 years. If current levels of diagnosis and treatment continue falling, achieving WHO's 2030 targets will be more challenging. With less than ten years remaining, screening and treatment expansion is crucial to meet WHO's HCV elimination targets.Keywords
Funding Information
- AbbVie
This publication has 11 references indexed in Scilit:
- Screening and Treatment Program to Eliminate Hepatitis C in EgyptNew England Journal of Medicine, 2020
- Screening for Hepatitis C Virus Infection in Adolescents and AdultsJAMA, 2020
- Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysisThe Lancet Global Health, 2020
- Global timing of hepatitis C virus elimination in high‐income countriesLiver International, 2019
- The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationClinical Infectious Diseases, 2019
- Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan AfricaJournal of Hepatology, 2019
- Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology CommissionThe Lancet Gastroenterology & Hepatology, 2019
- Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugsAddiction, 2018
- Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countriesHarm Reduction Journal, 2018
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling studyThe Lancet Gastroenterology & Hepatology, 2017